Federation des caisses Desjardins du Quebec’s Genomic Health, Inc. GHDX Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio GHDX Stock Details GHDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-16,728	Closed	-$1.13M	–	2402
2019 Q3	$1.13M	Sell	16,728 -1,033	-6%	-$70.9K	0.02%	612
2019 Q2	$1.03M	Buy	17,761 +4,849	+38%	+$287K	0.02%	637
2019 Q1	$905K	Buy	12,912 +6,619	+105%	+$491K	0.01%	631
2018 Q4	$406K	Buy	+6,293	New	+$441K	0.01%	761
2018 Q3	–	Sell	-375	Closed	-$18.9K	–	2219
2018 Q2	$18.9K	Buy	+375	New	+$14.9K	﹤0.01%	1582

Federation des caisses Desjardins du Quebec's GHDX Position: Q4 2019 in Review

Federation des caisses Desjardins du Quebec sold out of Genomic Health, Inc. (GHDX) in Q4 2019, closing a stake of 16,728 shares — an estimated $1.13M sold.

Federation des caisses Desjardins du Quebec first reported a position in GHDX in Q2 2018 and held it in 5 quarters. The position peaked at $1.13M in Q3 2019. 0 funds tracked by Wall St. Rank hold GHDX as of Q4 2019.

Federation des caisses Desjardins du Quebec reported no remaining Genomic Health, Inc. position as of Q4 2019 after selling out during the quarter.
Federation des caisses Desjardins du Quebec sold 16,728 Genomic Health, Inc. shares in Q4 2019, an estimated $1.13M.
Federation des caisses Desjardins du Quebec first reported a position in Genomic Health, Inc. in Q2 2018 and held it in 5 quarters.
Federation des caisses Desjardins du Quebec's Genomic Health, Inc. position peaked at $1.13M in Q3 2019.
0 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2019.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q4 2019, filed 30 Aug 2024.